Mitochondrial dysfunction and oxidative stress in bipolar disorder

Systems Biology of Free Radicals and Antioxidants

Volumn 9783642300189, Issue , 2014, Pages 2411-2429

  Tang, Victor ^a   Wang, Jun Feng ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Bipolar disorder; Mitochondrial dysfunction; Mood stabilizers; Neuroprotection; Oxidative damage; Reactive oxygen species

Indexed keywords

EID: 84934953030     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-30018-9_83     Document Type: Chapter

References (92)

1. Aliyazicioglu R, Kural B, Colak M, Karahan SC, Ayvaz S, Deger O (2007) Treatment with lithium, alone or in combination with olanzapine, relieves oxidative stress but increases atherogenic lipids in bipolar disorder. Tohoku J Exp Med 213:79-87
2. Allman JM, Hakeem A, Erwin JM, Nimchinsky E, Hof P (2001) The anterior cingulate cortex: The evolution of an interface between emotion and cognition. Ann N Y Acad Sci 935:107-117
3. Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA (2007a) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41:523-529
4. Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Goncalves CA, Kapczinski F (2007b) DNA damage in bipolar disorder. Psychiatry Res 153:27-32
5. Andreazza AC, Shao L, Wang JF, Young LT (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67:360-368
6. Bachmann RF, Wang Y, Yuan P, Zhou R, Li X, Alesci S, Du J, Manji HK (2009) Common effects of lithium and valproate on mitochondrial functions: protection against methamphetamineinduced mitochondrial damage. Int J Neuropsychopharmacol 12:805-822
7. Benes FM, Vincent SL, Todtenkopf (2001) The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry 50:395-406
8. Benes FM, Matzilevich D, Burke RE, Walsh J (2006) The expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia. Mol Psychiatry 11:241-251
9. Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder -A double-blind randomized placebo-controlled trial. Biol Psychiatry 64:468-475
10. Berk M, Dean O, Cotton SM, Gama CS, Kapczinski F, Fernandes BS, Kohlmann K, Jeavons S, Hewitt K, Allwang C, Cobb H, Bush AI, Schapkaitz I, Dodd S, Malhi GS (2011) The efficacy of N-acetylcysteine as an adjunctive treatment in bipolar depression: an open label trial. J Affect Disord (in press)
11. Berridge MJ (2012) Dysregulation of neural calcium signaling in Alzheimer disease, bipolar disorder and schizophrenia. Prion 6(5) [Epub ahead of print]
12. Beyer JL, Krishnan KR (2002) Volumetric brain imaging findings in mood disorders. Bipolar Disord 4:89-104
13. Billups B, Forsythe ID (2002) Presynaptic mitochondrial calcium sequestration influences transmission at mammalian central synapses. J Neurosci 22:5840-5847
14. Browne SE, Bowling AC, MacGarvey U, Baik MJ, Berger SC, Muqit M, Bird ED, Beal MF (1997) Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann Neurol 41:646-653
15. Buttner N, Bhattacharyya S, Walsh J, Benes FM (2007) DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia. Schizophr Res 93:33-41
16. Cantuti-Castelvetri I, Shukitt-Hale B, Joseph JA (2000) Neurobehavioral aspects of antioxidants in aging. Int J Dev Neurosci 18:367-381
17. Carlsson A, Waters N, Holm-Waters S, Tedroff J, Nilsson M, Carlsson ML (2001) Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence. Annu Rev Pharmacol Toxicol 41:237-260
18. Che Y, Wang JF, Shao L, Young T (2010) Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci 35:296-302
19. Chen C-H, Suckling J, Lennox BR, Ooi C, Bullmore ET (2011) A quantitative meta-analysis of fMRI studies in bipolar disorder. Bipolar Disord 13:1-15
20. Cheng R, Juo SH, Loth JE, Nee J, Iossifov I, Blumenthal R, Sharpe L, Kanyas K, Lerer B, Lilliston B, Smith M, Trautman K, Gilliam TC, Endicott J, Baron M (2006) Genome-wide linkage scan in a large bipolar disorder sample from the National Institute of Mental Health genetics initiative suggests putative loci for bipolar disorder, psychosis, suicide, and panic disorder. Mol Psychiatry 11:252-260
21. Chou YH, Wang SJ, Lin CL, Mao WC, Lee SM, Liao M (2010) Decreased brain serotonin transporter binding in the euthymic state of bipolar I but not bipolar II disorder: A SPECT study. Bipolar Disord 12:312-318
22. Clark L, Chamberlain SR, Sahakian BJ (2009) Neurocognitive mechanisms in depression: implications for treatment. Annu Rev Neurosci 32:57-74
23. Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29:311-324
24. Cousins DA, Butts K, Young AH (2009) The role of dopamine in bipolar disorder. Bipolar Disord 11:787-806
25. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695
26. Cui J, Shao L, Young LT, Wang JF (2007) Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 144:1447-1453
27. Dager SR, Friedman SD, Parow A, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF (2004) Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry 61:450-458
28. de Vasconcellos AP, Nieto FB, Crema LM, Diehl LA, de Almeida LM, Prediger ME, da Rocha ER, Dalmaz C (2006) Chronic lithium treatment has antioxidant properties but does not prevent oxidative damage induced by chronic variate stress. Neurochem Res 31:1141-1151
29. Dean OM, van den Buuse M, Bush AI, Copolov DL, Ng F, Dodd S, Berk M (2009) A role for glutathione in the pathophysiology of bipolar disorder and schizophrenia? Animal models and relevance to clinical practice. Curr Med Chem 16:2965-2976
30. Deicken RF, Fein G, WeinerMW(1995) Abnormal frontal lobe phosphorus metabolism in bipolar disorder. Am J Psychiatry 152:915-918
31. Detera-Wadleigh SD, Badner JA, Berrettini WH et al (1999) A high-density genome scan detects evidence for a bipolar-disorder susceptibility locus on 13q32 and other potential loci on 1q32 and 18p11.2. Proc Natl Acad Sci U S A 96:5604-5609
32. Diehl DJ, Gershon S (1992) The role of dopamine in mood disorders. Compr Psychiatry 33:115-120
33. Dodd S, Dean O, Copolov DL, Malhi GS, BerkM(2008) N-acetylcysteine for antioxidant therapy: pharmacology and clinical utility. Expert Opin Biol Ther 8:1955-1962
34. Douglas PM, Dillin A (2010) Protein homeostasis and aging in neurodegeneration. J Cell Biol 190:719-729
35. Dubovsky SL, Murphy J, Christiano J, Lee C (1992) The calcium second messenger system in bipolar disorders: data supporting new research directions. J Neuropsychiatry Clin Neurosci 4:3-14
36. Eastwood SL, Harrison PJ (2001) Synaptic pathology in the anterior cingulate cortex in schizophrenia and mood disorders. A review and a Western blot study of synaptophysin, GAP-43 and the complexins. Brain Res Bull 55:569-578
37. Esterling LE, Cox Matise T, Sanders AR, Yoshikawa T, Overhauser J, Gershon ES, Moskowitz MT, Detera-Wadleigh SD (1997) An integrated physical map of 18p11.2: A susceptibility region for bipolar disorder. Mol Psychiatry 2:501-504
38. Eyerman DJ, Yamamoto BK (2007) A rapid oxidation and persistent decrease in the vesicular monoamine transporter 2 after methamphetamine. J Neurochem 103:1219-1227
39. Finkel T, Holbrook NJ (2000) Oxidants, oxidative stress and the biology of ageing. Nature 408:239-247
40. Floyd RA (1999) Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 222:236-245
41. Frey BN, Valvassori SS, Reus GZ, Martins MR, Petronilho FC, Bardini K, Dal-Pizzol F, Kapczinski F, Quevedo J (2006) Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania. J Psychiatry Neurosci 31(5):326-332
42. Fukami G, Hashimoto K, Koike K, Okamura N, Shimizu E, Iyo M (2004) Effect of antioxidant Nacetyl-L-cysteine on behavioral changes and neurotoxicity in rats after administration of methamphetamine. Brain Res 1016:90-95
43. Fullerton JM, Tiwari Y, Agahi G, Heath A, Berk M, Mitchell PB, Schofield PR (2010) Assessing oxidative pathway genes as risk factors for bipolar disorder. Bipolar Disord 12:550-556
44. Gawryluk JW, Wang JF, Andreazza AC, Shao L, Young LT (2011) Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders. Int J Neuropsychopharmacol 14:123-130
45. Giniatullin AR, Darios F, Shakirzyanova A, Davletov B, Giniatullin R (2006) SNAP25 is a presynaptic target for the depressant action of reactive oxygen species on transmitter release. J Neurochem 98:1789-1797
46. Halliwell B (1997) What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo? FEBS Lett 441:157-160
47. Harman D (1956) Aging: A theory based on free radical and radiation chemistry. J Gerontol;11:298-300
48. Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large scale DNA microarray analysis. Hum Mol Genet 14:241-253
49. Jornada LK, Valvassori SS, Steckert AV, Moretti M, Mina F, Ferreira CL, Arent CO, Dal-Pizzol F, Quevedo J (2011) Lithium and valproate modulate antioxidant enzymes and prevent ouabaininduced oxidative damage in an animal model of mania. J Psychiatr Res 45:162-168
50. Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant'Anna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45:156-161
51. Kato T, Takahashi S, Shioiri T, Inubushi T (1993) Alterations in brain phosphorous metabolism in bipolar disorder detected by in vivo 31P and 7Li magnetic resonance spectroscopy. J Affect Disord 27:53-59
52. Kato T, Takahashi S, Shioiri T, Murashita J, Hamakawa H, Inubushi T (1994) Reduction of brain phosphocreatine in bipolar II disorder detected by phosphorus-31 magnetic resonance spectroscopy. J Affect Disord 31:125-133
53. Kato T, Shioiri T, Murashita J, Hamakawa H, Takahashi Y, Inubushi T, Takahashi S (1995) Lateralized abnormality of high energy phosphate metabolism in the frontal lobes of patients with bipolar disorder detected by phase-encoded 31P-MRS. Psychol Med 25:557-566
54. Kato T, Stine OC, McMahon FJ, Crowe RR (1997) Increased levels of a mitochondrial DNA deletion in the brain of patients with bipolar disorder. Biol Psychiatry 42:871-875
55. Kato T, Inubushi T, Kato N (1998) Magnetic resonance spectroscopy in affective disorders. J Neuropsychiatry Clin Neurosci 10:133-147
56. Konradi C, Eaton M, MacDonald ML, Walsh J, Benes FM, Heckers S (2004) Molecular evidence for mitochondrial dysfunction in bipolar disorder. Arch Gen Psychiatry 61:300-308
57. Lai JS, Zhao C, Warsh JJ, Li PP (2006) Cytoprotection by lithium and valproate varies between cell types and cellular stresses. Eur J Pharmacol 539:18-26
58. MacDonald ML, Naydenov A, Chu M, Matzilevich D, Konradi C (2006) Decrease in creatine kinase messenger RNA expression in the hippocampus and dorsolateral prefrontal cortex in bipolar disorder. Bipolar Disord 8:255-264
59. Machado-Vieira R, Andreazza AC, Viale CI, Zanatto V, Cereser V Jr, da Silva VR, Kapczinski F, Portela LV, Souza DO, Salvador M, Gentil V (2007) Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: A possible role for lithium antioxidant effects. Neurosci Lett 421:33-36
60. Magalhaes PV, Dean OM, Bush AI, Copolov DL, Malhi GS, Kohlmann K, Jeavons S, Schapkaitz I, Anderson-Hunt M, BerkM(2011) N-acetyl cysteine add-on treatment for bipolar II disorder: A subgroup analysis of a randomized placebo-controlled trial. J Affect Disord 129:317-320
61. Mann VM, Cooper JM, Krige D, Daniel SE, Schapira AH, Marsden CD (1992) Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. Brain 115(Pt 2):333-342
62. Martinowich K, Lu B (2008) Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33(1):73-83
63. Merikangas KR, Akiskal HS, Angst J, Greenberg PE, Hirschfeld RM, Petukhova M, Kessler RC (2007) Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 64:543-552
64. Miquel J (1992) An update on the mitochondrial-DNA mutation hypothesis of cell aging. Mutat Res 275:209-216
65. Munakata K, Tanaka M, Mori K, Washizuka S, Yoneda M, Tajima O, Akiyama T, Nanko S, Kunugi H, Tadokoro K, Ozaki N, Inada T, Sakamoto K, Fukunaga T, Iijima Y, Iwata N, Tatsumi M, Yamada K, Yoshikawa T, Kato T (2004) Mitochondrial DNA 3644T→C mutation associated with bipolar disorder. Genomics 84:1041-1050
66. Naoi M, Maruyama W, Shamoto-Nagai M, Yi H, Akao Y, Tanaka M (2005) Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 31:81-93
67. Pralong E, Magistretti P, Stoop R (2002) Cellular perspectives on the glutamate-monoamine interactions in limbic lobe structures and their relevance for some psychiatric disorders. Prog Neurobiol 67:173-202
68. Purdon AD, Rapoport SI (1998) Energy requirements for two aspects of phospholipid metabolism in mammalian brain. Biochem J 335:313-318
69. Quiroz JA, Gray NA, Kato T, Manji HK (2008) Mitochondrially mediated plasticity in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology 33:2551-2565
70. Radi R, Rodriguez M, Castro L, Telleri R (1994) Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308:89-95
71. Rajkowska G, Halaris A, Selemon LD (2001) Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry 9:741-752
72. Ressler KJ, Nemeroff CB (1999) Role of norepinephrine in the pathophysiology and treatment of mood disorders. Biol Psychiatry 46:1219-1233
73. Savas HA, Gergerlioglu HS, Armutcu F, Herken H, Yilmaz HR, Kocoglu E, Selek S, Tutkun H, Zoroglu SS, Akyol O (2006) Elevated serum nitric oxide and superoxide dismutase in euthymic bipolar patients: impact of past episodes. World J Biol Psychiatry 7:51-55
74. Sedvall G (1990) Monoamines and schizophrenia. Acta Psychiatr Scand Suppl 358:7-13
75. Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, YumruM(2008) The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 107:89-94
76. Shao L, Young LT, Wang JF (2005) Chronic treatment with mood stabilizers lithium and valproate prevents excitotoxicity by inhibiting oxidative stress in rat cerebral cortical cells. Biol Psychiatry 58:879-884
77. Shao L, Cui J, Young LT, Wang JF (2008) The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 151:518-524
78. Shukla GS (1987) Mechanism of lithium action: in vivo and in vitro effects of alkali metals on brain superoxide dismutase. Pharmacol Biochem Behav 26:235-240
79. Sun X, Wang JF, Tseng M, Young LT (2006) Downregulation in components of the mitochondrial electron transport chain in the postmortem frontal cortex of subjects with bipolar disorder. J Psychiatry Neurosci 31:189-196
80. Tan H, Shao L, Che Y, Young LT, Honer WG, Wang JF (2012) Mood stabilizer lithium prevents amphetamine-increased adductions of 4-hydroxynonenal with presynaptic proteins in rat frontal cortex. Int J Neuropsychopharmacol 15:1275-1285
81. Valvassori SS, Rezin GT, Ferreira CL, Moretti M, Gonçalves CL, Cardoso MR, Streck EL, Kapczinski F, Quevedo J (2010) Effects of mood stabilizers on mitochondrial respiratory chain activity in brain of rats treated with d-amphetamine. J Psychiatr Res 44:903-909
82. Wang JF, Azzam JE, Young LT (2003) Valproate inhibits oxidative damage to lipid and protein in primary cultured rat cerebrocortical cells. Neuroscience 116:485-489
83. Wang JF, Shao L, Sun X, Young LT (2004) Glutathione S-transferase is a novel target for mood stabilizing drugs in primary cultured neurons. J Neurochem 88:1477-1484
84. Wang ZJ, Liang CL, Li GM, Yu CY, Yin M (2006) Neuroprotective effects of arachidonic acid against oxidative stress on rat hippocampal slices. Chem Biol Interact 163:207-217
85. Wang JF, Shao L, Sun X, Young LT (2009) Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord 11:523-529
86. Wang JF, Tan H, Li HY, Shao L, Honer WG (2012) Oxidative modification of synaptosomal associated protein 25. The 16th biennial meeting for the Society for Free Radical Research International, Abstract HNE.P.6, London
87. Washizuka S, Iwamoto K, Kazuno AA, Kakiuchi C, Mori K, Kametani M, Yamada K, Kunugi H, Tajima O, Akiyama T, Nanko S, Yoshikawa T, Kato T (2004) Association of mitochondrial complex I subunit Gene NDUFV2 at 18p11 with bipolar disorder in Japanese and the national institute of mental health pedigrees. Biol Psychiatry 56:483-489
88. Washizuka S, Kakiuchi C, Mori K, Tajima O, Akiyama T, Kato T (2005) Expression of mitochondria-related genes in lymphoblastoid cells from patients with bipolar disorder. Bipolar Disord 7:146-152
89. Watabe M, Nakaki T (2008) Mitochondrial complex I inhibitor rotenone inhibits and redistributes vesicular monoamine transporter 2 via nitration in human dopaminergic SH-SY5Y cells. Mol Pharmacol 74:933-940
90. Wiste AK, Arango V, Ellis SP, Mann JJ, Underwood MD (2008) Norepinephrine and serotonin imbalance in the locus coeruleus in bipolar disorder. Bipolar Disord 10:349-359
91. Xu C, Li PP, Kennedy JL, Green M, Hughes B, Cooke RG, Parikh SV, Warsh JJ (2008) Further support for association of the mitochondrial complex I subunit gene NDUFV2 with bipolar disorder. Bipolar Disord 10:105-110
92. Yildiz A, Sachs GS, Dorer DJ, Renshaw PF (2001) 31P nuclear magnetic resonance spectroscopy findings in bipolar illness: A meta-analysis. Psychiatry Res 106:181-191